Daily Round Up 3/30/16: Care Capital Properties, Evine Live, Shake Shack, Community Shores Bank

by: InsiderInsights


Tables of the top insider purchases and sales filed with the SEC on 3/30/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

Educational note from InsiderInsights:

Insider filing volumes are at a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily round Up articles (particularly the purchases) will likely be lower than usual until early May.

On Today's Tables:

Insider trades were rated Significant at:

  • Shake Shack (NYSE:SHAK);
  • Evine Live (NASDAQ:EVLV);
  • Virtus Total Return Fund (DCA);
  • Community Shores Bank (OTCPK:CSHB), and;
  • Care Capital Properties (CCP).

Insider trades were rated Nearly Significant at:

  • United States Antimony (NYSEMKT:UAMY), and;
  • Salesforce Com (NYSE:CRM).

Insider trades were considered Insignificant at:

  • Six Flags Ent (NYSE:SIX);
  • Shenandoah Telecommunications (NASDAQ:SHEN);
  • Primo Water (NASDAQ:PRMW);
  • Alphabet (NASDAQ:GOOG), and;
  • Accenture (NYSE:ACN).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Southwest Gas (NYSE:SWX);
  • Nimble Storage (NYSE:NMBL);
  • Mattress Firm (NASDAQ:MFRM), and;
  • Juno Therapeutics (NASDAQ:JUNO).

There is an IPO or Known Corporate Action at:

  • Corvus Pharm (NASDAQ:CRVS).

It's difficult to argue significance for most transactions made during IPOs, or when insiders make trades during a known corporate action.

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Parks Daniel Lyle CFO United States Antimony UAMY JB* $30,062,500
2 Novo A S BO Corvus Pharm CRVS JB* $9,999,990
3 Berkshire Partners BO Mattress Firm MFRM B $9,807,223
4 Essex Bruce J DIR,BO Community Shores Bank CSHB JB* $1,780,078
5 Chandonnet Robert L DIR,BO Community Shores Bank CSHB JB* $1,265,860
6 Lewis Raymond J CEO,DIR Care Capital Properties CCP B $513,846
7 Bulldog Investors BO Virtus Total Return Fund DCA B $490,960
8 Rosenblatt Robert CEO,DIR Evine Live EVLV B $294,829
9 Evnin Anthony B DIR Juno Therapeutics JUNO B $292,662
10 Schroeder William John DIR Nimble Storage NMBL B $282,934

Source: | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Brin Sergey PR,DIR,BO Alphabet GOOG AS $12,645,220
2 Reid Anderson J CB,DIR Six Flags Ent SIX AS $6,561,588
3 Select Equity DIR Shake Shack SHAK S $5,118,500
4 Acg Shack BO Shake Shack SHAK S $3,960,849
5 Benioff Marc CB,CEO Salesforce Com CRM AS $1,823,419
6 Shaw Jeffrey W DIR Southwest Gas SWX S $1,445,549
7 Casati Gianfranco CEO Accenture ACN AS $1,375,536
8 Mackenzie Earle A VP Shenandoah Telecommunications SHEN S $1,282,173
9 Warnock David L DIR Primo Water PRMW S $942,335
10 Van T Noordende Alexander M CEO Accenture ACN AS $908,571 | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.